Alpha Cognition (ACOG) Competitors

Alpha Cognition (NASDAQ:ACOG) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends, valuation and community ranking.

Do institutionals and insiders hold more shares of ACOG or HRTX?

80.0% of Heron Therapeutics shares are owned by institutional investors. 31.5% of Alpha Cognition shares are owned by company insiders. Comparatively, 5.8% of Heron Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media refer more to ACOG or HRTX?

In the previous week, Alpha Cognition had 7 more articles in the media than Heron Therapeutics. MarketBeat recorded 9 mentions for Alpha Cognition and 2 mentions for Heron Therapeutics. Heron Therapeutics' average media sentiment score of 1.73 beat Alpha Cognition's score of 0.98 indicating that Heron Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heron Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility and risk, ACOG or HRTX?

Alpha Cognition has a beta of 2.5, indicating that its stock price is 150% more volatile than the S&P 500. Comparatively, Heron Therapeutics has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500.

Do analysts rate ACOG or HRTX?

Alpha Cognition presently has a consensus target price of $20.00, indicating a potential upside of 262.32%. Heron Therapeutics has a consensus target price of $5.67, indicating a potential upside of 147.45%. Given Alpha Cognition's higher possible upside, equities analysts clearly believe Alpha Cognition is more favorable than Heron Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Heron Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is ACOG or HRTX more profitable?

Alpha Cognition has a net margin of 0.00% compared to Heron Therapeutics' net margin of -20.31%.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	N/A	N/A	-344.17%
Heron Therapeutics	-20.31%	N/A	-12.72%

Does the MarketBeat Community prefer ACOG or HRTX?

Heron Therapeutics received 666 more outperform votes than Alpha Cognition when rated by MarketBeat users. Likewise, 68.83% of users gave Heron Therapeutics an outperform vote while only 50.00% of users gave Alpha Cognition an outperform vote.

Company	Underperform	Outperform
Alpha Cognition	Outperform Votes 1 50.00%	Underperform Votes 1 50.00%
Heron Therapeutics	Outperform Votes 667 68.83%	Underperform Votes 302 31.17%

Which has stronger valuation & earnings, ACOG or HRTX?

Alpha Cognition has higher earnings, but lower revenue than Heron Therapeutics. Heron Therapeutics is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	N/A	N/A	-$13.77M	-$2.56	-2.16
Heron Therapeutics	$144.29M	2.42	-$110.56M	-$0.09	-25.44

Summary

Heron Therapeutics beats Alpha Cognition on 8 of the 15 factors compared between the two stocks.